The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID-19 Pandemic
- PMID: 39760467
- PMCID: PMC11748096
- DOI: 10.1002/ppul.27474
The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID-19 Pandemic
Abstract
Background: Respiratory syncytial virus (RSV) infection in the first year of life has been linked with an increased risk for asthma. Some propose that RSV-induced inflammation leads to lasting airway changes, while others contend that RSV bronchiolitis is a marker for underlying predisposition. Social distancing adopted during the COVID-19 pandemic has led to a dramatic reduction in RSV activity, providing an unexpected opportunity to investigate this debate.
Objective: To compare the incidence of asthma-related healthcare-utilization (HCU) in 1-3 years of age between children born in March-June 2020 (l-RSV) and children born during the same months in the years 2014-2017 (H-RSV).
Study design and methods: This retrospective study utilized nationwide healthcare database records from Clalit-Healthcare-Services, the largest healthcare organization in Israel. The study analyzed asthma-related HCU, using multivariate logistic regression and Bayesian analyses.
Results: 172,463 children were included in the study: 32,927 in the l-RSV group versus 139,536 in the H-RSV group. The l-RSV cohort showed insignificant changes and increased rates of asthma-related HCU between 1 and 3 years of age in some asthma surrogates, compared to the H-RSV group.
Conclusion: Reduction in RSV exposure during the first year of life did not correlate with a decrease in asthma-related HCU. This may imply that RSV infection in infancy functions as an indicator of underlying predisposition rather than a direct cause of asthma.
© 2025 The Author(s). Pediatric Pulmonology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Li Y., Wang X., Blau D. M., et al., “Global, Regional, and National Disease Burden Estimates of Acute Lower Respiratory Infections Due to Respiratory Syncytial Virus in Children Younger Than 5 Years in 2019: A Systematic Analysis,” The Lancet 399, no. 10340 (May 2022): 2047–2064, 10.1016/S0140-6736(22)00478-0. - DOI - PMC - PubMed
-
- Stockman L. J., Curns A. T., Anderson L. J., and Fischer‐Langley G., “Respiratory Syncytial Virus‐Associated Hospitalizations Among Infants and Young Children in the United States, 1997–2006,” Pediatric Infectious Disease Journal 31, no. 1 (Jan 2012): 5–9, 10.1097/INF.0b013e31822e68e6. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
